(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 11.78%
-0.81% $ 1.220
Live Chart Being Loaded With Signals
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 202 091 |
Średni wolumen | 220 879 |
Kapitalizacja rynkowa | 54.73M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.360 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 4.52 |
ATR14 | $0.00500 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-01 | Golipour Azadeh | Sell | 37 334 | Restricted Stock Unit |
2024-02-01 | Golipour Azadeh | Buy | 37 334 | Common Stock |
2024-02-05 | Golipour Azadeh | Sell | 12 232 | Common Stock |
2024-02-01 | Ridha Essra | Sell | 32 834 | Restricted Stock Unit |
2024-02-01 | Ridha Essra | Buy | 32 834 | Common Stock |
INSIDER POWER |
---|
54.75 |
Last 100 transactions |
Buy: 6 327 240 | Sell: 1 294 974 |
Wolumen Korelacja
AVROBIO Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TLS | 0.933 |
MBIN | 0.909 |
HUBG | 0.893 |
ALLK | 0.892 |
PMBC | 0.888 |
BNGO | 0.885 |
NBTB | 0.884 |
ITOS | 0.876 |
ATNX | 0.873 |
CLOV | 0.873 |
10 Najbardziej negatywne korelacje | |
---|---|
AAON | -0.865 |
DPCS | -0.861 |
GRPH | -0.851 |
BNIXU | -0.845 |
KVSC | -0.845 |
CINC | -0.844 |
SGEN | -0.842 |
IPAR | -0.841 |
BCOR | -0.839 |
PRTC | -0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AVROBIO Inc Korelacja - Waluta/Towar
AVROBIO Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-617 000 (0.00 %) |
EPS: | $0.270 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-617 000 (0.00 %) |
EPS: | $0.270 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-4.17M (0.00 %) |
EPS: | $-2.42 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.78 |
Financial Reports:
No articles found.
AVROBIO Inc
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej